- ABBV has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $660.5 million.
- ABBV traded 95,169 shares today in the pre-market hours as of 7:41 AM.
- ABBV is down 4.6% today from Friday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ABBV with the Ticky from Trade-Ideas. See the FREE profile for ABBV NOW at Trade-Ideas More details on ABBV: AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The stock currently has a dividend yield of 2.8%. ABBV has a PE ratio of 23.0. Currently there are 5 analysts that rate AbbVie a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for AbbVie has been 11.7 million shares per day over the past 30 days. AbbVie has a market cap of $94.6 billion and is part of the health care sector and drugs industry. Shares are up 11.8% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates AbbVie as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth and increase in net income. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and generally higher debt management risk.